Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.16B | 38.63B | 35.95B | 32.57B | 27.72B | 20.40B |
Gross Profit | 19.96B | 22.34B | 17.86B | 18.56B | 15.81B | 11.39B |
EBITDA | 10.36B | 11.10B | 9.97B | 8.22B | 7.10B | 4.24B |
Net Income | 5.64B | 5.87B | 5.38B | 4.13B | 3.24B | 1.11B |
Balance Sheet | ||||||
Total Assets | 33.25B | 34.71B | 32.73B | 29.98B | 28.95B | 26.42B |
Cash, Cash Equivalents and Short-Term Investments | 10.93B | 11.50B | 11.42B | 10.08B | 9.39B | 7.57B |
Total Debt | 5.24B | 7.13M | 5.74B | 5.60B | 6.01B | 6.35B |
Total Liabilities | 16.70B | 15.04B | 14.06B | 12.95B | 13.19B | 11.87B |
Stockholders Equity | 16.51B | 19.68B | 18.64B | 17.01B | 15.73B | 14.52B |
Cash Flow | ||||||
Free Cash Flow | 1.48B | 6.62B | 6.80B | 5.26B | 5.63B | 2.31B |
Operating Cash Flow | 1.48B | 9.29B | 8.67B | 6.67B | 6.75B | 3.02B |
Investing Cash Flow | 0.00 | -3.29B | -1.71B | -3.50B | -3.25B | 2.51B |
Financing Cash Flow | 0.00 | -6.61B | -5.47B | -4.61B | -3.91B | -2.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $161.00B | 25.45 | 32.29% | 4.85% | 5.58% | 6.38% | |
74 Outperform | $139.80B | 29.55 | 60.36% | 1.36% | 3.79% | 5.23% | |
71 Outperform | $8.42B | 9.83 | 29.16% | 2.92% | 1.07% | 28.03% | |
71 Outperform | $15.28B | 29.74 | 44.13% | ― | 8.29% | 38.09% | |
66 Neutral | $43.02B | 20.80 | 39.57% | 1.23% | 2.49% | 6.60% | |
66 Neutral | £1.85B | 11.29 | 6.20% | 3.10% | 0.61% | -17.57% | |
64 Neutral | $30.63B | 16.81 | 42.49% | ― | 9.39% | 17.28% |